Triplixam 5 mg/1,25 mg/10 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

triplixam 5 mg/1,25 mg/10 mg filmom obložene tablete

servier pharma d.o.o., ulica grge tuškana 37, zagreb, hrvatska - perindoprilarginin indapamid amlodipinbesilat - filmom obložena tableta - 5 mg + 1,25 mg + 10 mg - urbroj: jedna filmom obložena tableta sadrži 3,395 mg perindoprila što odgovara 5 mg perindoprilarginina, 1,25 mg indapamida i 13,870 mg amlodipinbesilata što odgovara 10 mg amlodipina

Triplixam 5 mg/1,25 mg/5 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

triplixam 5 mg/1,25 mg/5 mg filmom obložene tablete

servier pharma d.o.o., ulica grge tuškana 37, zagreb, hrvatska - perindoprilarginin indapamid amlodipinbesilat - filmom obložena tableta - 5 mg + 1,25 mg + 5 mg - urbroj: jedna filmom obložena tableta sadrži 3,395 mg perindoprila što odgovara 5 mg perindoprilarginina, 1,25 mg indapamida i 6,935 mg amlodipinbesilata što odgovara 5 mg amlodipina

Olumiant Europska Unija - hrvatski - EMA (European Medicines Agency)

olumiant

eli lilly nederland b.v. - baricitinib - artritis, reumatoidni - imunosupresivi - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumiant se može koristiti kao monoterapija ili u kombinaciji s metotreksatom. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.

Rasilamlo Europska Unija - hrvatski - EMA (European Medicines Agency)

rasilamlo

novartis europharm ltd - алискирена, амлодипина - hipertenzija - sredstva koja djeluju na sustav renin-angiotenzina - rasilamlo je indiciran za liječenje esencijalne hipertenzije u odraslih bolesnika čiji krvni tlak nije odgovarajuće kontroliran sa lijekovima ili amlodipin koristiti samo.

Hemlibra Europska Unija - hrvatski - EMA (European Medicines Agency)

hemlibra

roche registration limited - emicizumab - hemofilija a - antihemorrhagics - hemlibra is indicated for routine prophylaxis of bleeding episodes in patients with haemophilia a (congenital factor viii deficiency):with factor viii inhibitorswithout factor viii inhibitors who have:severe disease (fviii < 1%)moderate disease (fviii ≥ 1% and ≤ 5%) with severe bleeding phenotype. hemlibra mogu se koristiti u svim dobnim skupinama.

Zinforo Europska Unija - hrvatski - EMA (European Medicines Agency)

zinforo

pfizer ireland pharmaceuticals - fosamil цефтаролин - community-acquired infections; skin diseases, infectious; pneumonia - antibakterijski lijekovi za sistemsku primjenu, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.

Natrixam 1,5 mg/5 mg tablete s prilagođenim oslobađanjem Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

natrixam 1,5 mg/5 mg tablete s prilagođenim oslobađanjem

servier pharma d.o.o., tuškanova 37, zagreb, hrvatska - indapamid amlodipinbesilat - tableta s prilagođenim oslobađanjem - 1,5 mg + 5 mg - urbroj: jedna tableta sadrži 1,5 mg indapamida i 6,935 mg amlodipinbesilata što odgovara 5 mg amlodipina

Prestilol 5 mg/10 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

prestilol 5 mg/10 mg filmom obložene tablete

servier pharma d.o.o., tuškanova 37, zagreb, hrvatska - bisoprololfumarat perindoprilarginin - filmom obložena tableta - 5 mg + 10 mg - urbroj: jedna filmom obložena tableta sadrži 5 mg bisoprololfumarata (što odgovara 4,24 mg bisoprolola) i 10 mg perindoprilarginina (što odgovara 6,790 mg perindoprila)

Prestilol 5 mg/5 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

prestilol 5 mg/5 mg filmom obložene tablete

servier pharma d.o.o., tuškanova 37, zagreb, hrvatska - bisoprololfumarat perindoprilarginin - filmom obložena tableta - 5 mg + 5 mg - urbroj: jedna filmom obložena tableta sadrži 5 mg bisoprololfumarata (što odgovara 4,24 mg bisoprolola) i 5 mg perindoprilarginina (što odgovara 3,395 mg perindoprila)

Lextemy Europska Unija - hrvatski - EMA (European Medicines Agency)

lextemy

mylan ire healthcare limited - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastična sredstva - treatment of carcinoma of the colon or rectum, breast cancer, non-small cell lung cancer, renal cell cancer, epithelial ovarian, fallopian tube or primary peritoneal cancer, and carcinoma of the cervix.